Today news
About the same in other media
AstraZeneca gets GCGI approval to import heart failure drug
Reading now: 647
AstraZeneca Pharma India on Monday said it has received approval from the Drugs Controller General of India to import heart failure treatment drug Dapagliflozin tablets. The company has received permission from the DCGI to import pharmaceutical formulations of a new drug for sale, the drug firm said in a regulatory filing.
Dapagliflozin tablets are indicated for the treatment of heart failure in adults, it added. The receipt of this permission paves the way for the launch of the product in India for the specified indication, subject to the receipt of related statutory approvals and licenses, it said.
Read more on economictimes.indiatimes.comAbout this in other media
Indian YouTuber gets I-T notice with ₹2.6 crore dues; then he finds THIS: Report livemint.com /1 year ago
Sudha Murty gets trolled for carrying food during foreign visits; Here's why livemint.com /1 year ago
TVS Supply Chain Solutions gets Sebi's nod for IPO launch. Details here livemint.com /1 year ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
